Skip to main content
. 2019 Apr 23;5(4):e01543. doi: 10.1016/j.heliyon.2019.e01543

Fig. 8.

Fig. 8

Plates showing the antimicrobial activities of biosynthesized GPAgNPs against: (A) C. albicans (B) P. aeruginosa (C) K. pneumonia (D) E. coli.